Literature DB >> 21107421

Cancer: The blind spot of p53.

Anton Berns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21107421     DOI： 10.1038/468519a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

Review 1.  Divorcing ARF and p53: an unsettled case.

Authors:  Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

2.  Restoration of p53 function leads to tumour regression in vivo.

Authors:  Andrea Ventura; David G Kirsch; Margaret E McLaughlin; David A Tuveson; Jan Grimm; Laura Lintault; Jamie Newman; Elizabeth E Reczek; Ralph Weissleder; Tyler Jacks
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

3.  Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.

Authors:  Wen Xue; Lars Zender; Cornelius Miething; Ross A Dickins; Eva Hernando; Valery Krizhanovsky; Carlos Cordon-Cardo; Scott W Lowe
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

4.  Modeling the therapeutic efficacy of p53 restoration in tumors.

Authors:  Carla P Martins; Lamorna Brown-Swigart; Gerard I Evan
Journal:  Cell       Date:  2006-12-21       Impact factor: 41.582

5.  The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.

Authors:  M A Christophorou; I Ringshausen; A J Finch; L Brown Swigart; G I Evan
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

Review 6.  Tumour suppression by p53: a role for the DNA damage response?

Authors:  David W Meek
Journal:  Nat Rev Cancer       Date:  2009-09-04       Impact factor: 60.716

7.  Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.

Authors:  Lynette Moore; Sundaresan Venkatachalam; Hannes Vogel; Julie C Watt; Chao-Ling Wu; Heather Steinman; Stephen N Jones; Lawrence A Donehower
Journal:  Oncogene       Date:  2003-10-30       Impact factor: 9.867

8.  Stage-specific sensitivity to p53 restoration during lung cancer progression.

Authors:  David M Feldser; Kamena K Kostova; Monte M Winslow; Sarah E Taylor; Chris Cashman; Charles A Whittaker; Francisco J Sanchez-Rivera; Rebecca Resnick; Roderick Bronson; Michael T Hemann; Tyler Jacks
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962

9.  Selective activation of p53-mediated tumour suppression in high-grade tumours.

Authors:  Melissa R Junttila; Anthony N Karnezis; Daniel Garcia; Francesc Madriles; Roderik M Kortlever; Fanya Rostker; Lamorna Brown Swigart; David M Pham; Youngho Seo; Gerard I Evan; Carla P Martins
Journal:  Nature       Date:  2010-11-25       Impact factor: 49.962
  9 in total
  8 in total

1.  Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells.

Authors:  Xue-Yuan Dong; Peng Guo; Xiaodong Sun; Qunna Li; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

Review 2.  RNAi: a potential new class of therapeutic for human genetic disease.

Authors:  Attila A Seyhan
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

Review 3.  p63 the guardian of human reproduction.

Authors:  Ivano Amelio; Francesca Grespi; Margherita Annicchiarico-Petruzzelli; Gerry Melino
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

4.  Runx3 plays a critical role in restriction-point and defense against cellular transformation.

Authors:  X-Z Chi; J-W Lee; Y-S Lee; I Y Park; Y Ito; S-C Bae
Journal:  Oncogene       Date:  2017-08-28       Impact factor: 9.867

5.  AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma.

Authors:  Ryan D Chow; Christopher D Guzman; Guangchuan Wang; Florian Schmidt; Mark W Youngblood; Lupeng Ye; Youssef Errami; Matthew B Dong; Michael A Martinez; Sensen Zhang; Paul Renauer; Kaya Bilguvar; Murat Gunel; Phillip A Sharp; Feng Zhang; Randall J Platt; Sidi Chen
Journal:  Nat Neurosci       Date:  2017-08-14       Impact factor: 24.884

6.  Molecular dynamics of the full-length p53 monomer.

Authors:  Giovanni Chillemi; Pavel Davidovich; Marco D'Abramo; Tazhir Mametnabiev; Alexander Vasilievich Garabadzhiu; Alessandro Desideri; Gerry Melino
Journal:  Cell Cycle       Date:  2013-09-05       Impact factor: 4.534

7.  Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study.

Authors:  Balu Kamaraj; Annemie Bogaerts
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

8.  Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer.

Authors:  Jun Liu; Qiwen Ben; Eryi Lu; Xiangyi He; Xiaoqun Yang; Jun Ma; Wen Zhang; Zhiming Wang; Tianshu Liu; Jianjun Zhang; Hongxia Wang
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.